By contrast, mIL‐33 may potentiate lung fibrosis by recruiting ST2L+M2‐macrophages and ST2L+ILC2s to enlarge Th2 cytokine milieu by excessive production of IL‐4, IL‐5, and IL‐13. The gene discussed is IL5; the disease is pulmonary fibrosis.